Listed

Universal Health Services Inc

UHSNYSECIK 352915HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$4.64bnRevenue, Q2 FY2026, three months to 2026-06-30$4.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 7, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$4.64bnRevenue, Q2 FY2026, three months to 2026-06-30$4.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure+8.3% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin11.1%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $516.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Revenue: $4.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure−0.5 pts on a year earlier
  • Net margin7.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $358.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Revenue: $4.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure−0.5 pts on a year earlier
  • Diluted EPS$5.98Diluted EPS, Q2 FY2026, three months to 2026-06-30$5.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure+10.1% on a year earlier
  • Free cash flow$215.7mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $443.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340278. Derived: 6-month figure less the 3-month figure.Capital expenditure: $227.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-340278. Derived: 6-month figure less the 3-month figure.Report this figure−23.8% on a year earlier

Last eight quarters

Full statements
Revenue$4.64bnOperating margin 11.1%
Diluted EPS$5.98, Q2 FY2026
Free cash flow$215.7m, Q2 FY2026
Universal Health Services Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m3,963Revenue, Q3 FY2024, three months to 2024-09-30$3.96bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figure4,114Revenue, Q4 FY2024, three months to 2024-12-31$4.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure4,100Revenue, Q1 FY2025, three months to 2025-03-31$4.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure4,284Revenue, Q2 FY2025, three months to 2025-06-30$4.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure4,495Revenue, Q3 FY2025, three months to 2025-09-30$4.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figure4,486Revenue, Q4 FY2025, three months to 2025-12-31$4.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure4,495Revenue, Q1 FY2026, three months to 2026-03-31$4.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure4,638Revenue, Q2 FY2026, three months to 2026-06-30$4.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%9.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $384.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Revenue: $3.96bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figure11.5%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $472.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Revenue: $4.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure11.1%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $454.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Revenue: $4.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure11.7%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $500.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Revenue: $4.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure11.6%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $521.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Revenue: $4.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figure11.5%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $517.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Revenue: $4.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure11.2%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $502.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Revenue: $4.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure11.1%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $516.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Revenue: $4.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure
Net margin%6.5%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $258.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Revenue: $3.96bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figure8.1%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $332.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Revenue: $4.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure7.7%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $316.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Revenue: $4.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure8.2%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $353.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Revenue: $4.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure8.3%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $373.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Revenue: $4.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figure9.9%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $445.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Revenue: $4.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure7.8%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $348.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Revenue: $4.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure7.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $358.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Revenue: $4.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure
Diluted EPS$ per share3.80Diluted EPS, Q3 FY2024, three months to 2024-09-30$3.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figurenot reported (Diluted EPS not reported)4.80Diluted EPS, Q1 FY2025, three months to 2025-03-31$4.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure5.43Diluted EPS, Q2 FY2025, three months to 2025-06-30$5.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure5.86Diluted EPS, Q3 FY2025, three months to 2025-09-30$5.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272385.Report this figurenot reported (Diluted EPS not reported)5.65Diluted EPS, Q1 FY2026, three months to 2026-03-31$5.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure5.98Diluted EPS, Q2 FY2026, three months to 2026-06-30$5.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340278.Report this figure
Free cash flow$m85.0Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $333.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272385. Derived: 9-month figure less the 6-month figure.Capital expenditure: $247.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272385. Derived: 9-month figure less the 6-month figure.Report this figure412Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $658.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Capital expenditure: $245.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure121Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $360.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Capital expenditure: $239.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure283Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $549.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340278. Derived: 6-month figure less the 3-month figure.Capital expenditure: $266.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-340278. Derived: 6-month figure less the 3-month figure.Report this figure152Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $380.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272385. Derived: 9-month figure less the 6-month figure.Capital expenditure: $228.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272385. Derived: 9-month figure less the 6-month figure.Report this figure293Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $574.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Capital expenditure: $281.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071676. Derived: 12-month figure less the 9-month figure.Report this figure184Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $401.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Capital expenditure: $217.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211992.Report this figure216Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $443.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340278. Derived: 6-month figure less the 3-month figure.Capital expenditure: $227.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-340278. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$17.36bnOperating margin 11.5%
Diluted EPS$23.10, FY2025
Free cash flow$849.2m, FY2025
Universal Health Services Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$bn12.6Revenue, FY2021, twelve months to 2021-12-31$12.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021175.Report this figure13.4Revenue, FY2022, twelve months to 2022-12-31$13.40bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0000950170-25-027785.Report this figure14.3Revenue, FY2023, twelve months to 2023-12-31$14.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure15.8Revenue, FY2024, twelve months to 2024-12-31$15.83bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure17.4Revenue, FY2025, twelve months to 2025-12-31$17.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%10.8%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $1.36bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-27, accession 0000950170-24-021175.Revenue: $12.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021175.Report this figure7.5%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $1.00bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-26, accession 0000950170-25-027785.Revenue: $13.40bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0000950170-25-027785.Report this figure8.2%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $1.18bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676.Revenue: $14.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure10.6%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $1.68bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676.Revenue: $15.83bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure11.5%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $1.99bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676.Revenue: $17.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure
Net margin%7.8%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $991.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-27, accession 0000950170-24-021175.Revenue: $12.64bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021175.Report this figure5.0%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $675.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-26, accession 0000950170-25-027785.Revenue: $13.40bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0000950170-25-027785.Report this figure5.0%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $717.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676.Revenue: $14.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure7.2%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $1.14bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676.Revenue: $15.83bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure8.6%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $1.49bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071676.Revenue: $17.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure
Diluted EPS$ per share11.82Diluted EPS, FY2021, twelve months to 2021-12-31$11.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-27, accession 0000950170-24-021175.Report this figure9.14Diluted EPS, FY2022, twelve months to 2022-12-31$9.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-26, accession 0000950170-25-027785.Report this figure10.23Diluted EPS, FY2023, twelve months to 2023-12-31$10.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure16.82Diluted EPS, FY2024, twelve months to 2024-12-31$16.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure23.10Diluted EPS, FY2025, twelve months to 2025-12-31$23.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure
Free cash flow$bn0.0Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $883.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-27, accession 0000950170-24-021175.Capital expenditure: $855.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-27, accession 0000950170-24-021175.Report this figure0.3Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $996.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-26, accession 0000950170-25-027785.Capital expenditure: $734.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-26, accession 0000950170-25-027785.Report this figure0.5Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $1.27bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071676.Capital expenditure: $743.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure1.1Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $2.07bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071676.Capital expenditure: $943.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure0.8Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $1.86bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071676.Capital expenditure: $1.02bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071676.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Universal Health Services Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
First Eagle Investment Management, LLC2026-06-30$677.2m4,554,670Added+130,389
First Eagle Investment Management, LLC2026-06-30$677.2m4,554,670Added+130,389
BlackRock, Inc.2026-06-30$603.7m4,059,826Reduced−285,257
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$504.4m3,392,199Reduced−60,686
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$364.6m2,452,177Reduced−55,990
DIMENSIONAL FUND ADVISORS LP2026-06-30$328.7m2,210,595Added+429,333
STATE STREET CORP2026-06-30$312.6m2,102,613Reduced−476,776
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$293.2m1,974,065Added+26,197
PZENA INVESTMENT MANAGEMENT LLC2026-06-30$292.8m1,969,327Added+57,092
Invesco Ltd.2026-06-30$290.1m1,951,147Added+362,027

Recent filings

All 1,131 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Universal Health Services Inc, recent filings
FiledFormWhat it isAccession number
2026-10-2717:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-434414
2026-08-2107:58 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-359953
2026-08-1716:15 ET8-K2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-354078
2026-08-1309:23 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-26-348057
2026-08-0716:15 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-340278
2026-07-2808:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-318940
2026-07-2116:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-310330
2026-05-2207:30 ET8-K5.07 Shareholder vote results0001193125-26-235480
2026-05-2107:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-233402
2026-05-0716:17 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-211992

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested.See the target

About the filer

CIK
352915
Tickers
UHS
Exchange
NYSE
SIC code
8062 Services-General Medical & Surgical Hospitals, NEC
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:04 ET. Listed shows no prices and gives no investment advice.